• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Click Therapeutics

Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia

September 21, 2020 by SharpBrains

Boehringer Ingel­heim, Click Ther­a­peu­tics ink $500M+ dig­i­tal ther­a­peu­tics devel­op­ment, com­mer­cial­iza­tion deal (Mobi­Health­News):

Inter­na­tion­al phar­ma Boehringer Ingel­heim and pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Click Ther­a­peu­tics have inked a $500 mil­lion-plus deal to joint­ly devel­op and com­mer­cial­ize a dig­i­tal treat­ment for patients with schiz­o­phre­nia. [Read more…] about Click Ther­a­peu­tics and Boehringer Ingel­heim part­ner to devel­op and mar­ket a dig­i­tal ther­a­peu­tic to treat schizophrenia

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: Boehringer Ingelheim, Click Therapeutics, CT-155, digital therapeutic, digital treatment, disorders, neuropsychiatric, neuropsychiatric disorders, pharma, prescription-based, schizophrenia

Trend: Pharma industry warming up to digital therapeutics

August 22, 2019 by SharpBrains

– Som­ryst app by Pear Therapeutics

Dig­i­tal ther­a­peu­tics have poten­tial but com­mer­cial suc­cess unproven (Van­tage):

“Devel­op­ing drugs to treat dis­or­ders of the cen­tral ner­vous sys­tem is famous­ly fraught with dif­fi­cul­ty. Sev­er­al com­pa­nies, includ­ing Pear Ther­a­peu­tics and Dthera, are tak­ing a wild­ly dif­fer­ent approach: dig­i­tal ther­a­peu­tics. These are pieces of soft­ware designed to treat dis­ease that are reg­u­lat­ed, pre­scribed and even paid for as if they were drugs … Pear is so far the only com­pa­ny to have brought a dig­i­tal ther­a­peu­tic to mar­ket – but it is by no means the only com­pa­ny in this space. Akili Inter­ac­tive has­filed for FDA approval of AKL-T01, a com­put­er game designed to treat ADHD, and [Read more…] about Trend: Phar­ma indus­try warm­ing up to dig­i­tal therapeutics

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: Akili Interactive, AKL-T01, Click Therapeutics, cognitive dysfunction, digital therapeutics, Dthera, Pear Therapeutics, Somryst

How to intervene early to address brain/ mental health problems: Examples in depression, epilepsy and smoking cessation

July 18, 2019 by SharpBrains

How to inter­vene ear­ly: Exam­ples in depres­sion, epilep­sy and smok­ing ces­sa­tion from Sharp­Brains

We hope you enjoy this slid­edeck sup­port­ing a fas­ci­nat­ing, for­ward-look­ing ses­sion held at the 2019 Sharp­Brains Vir­tu­al Sum­mit: The Future of Brain Health (March 7–9th).  Full record­ings are avail­able for pur­chase here.

10.45am-12.15pm. How to inter­vene ear­ly: Exam­ples in depres­sion, epilep­sy and smok­ing cessation 

  • Dr. Wal­ter Green­leaf, Research Sci­en­tist at Stan­ford University’s Vir­tu­al Human Inter­ac­tion Lab
  • David B. Klein, CEO of Click Ther­a­peu­tics
  • Ana Maiques, CEO of Neu­ro­electrics
  • Chaired by: Avery Bedows, Neu­rotech­nol­o­gy Spe­cial­ist at Loup Ven­tures

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: brain health, Click Therapeutics, depression, epilepsy, Loup Ventures, mental health, Neuroelectrics, problems, smoking cessation, Stanford-University

10+ pioneers confirmed to Speak @ 2019 SharpBrains Virtual Summit (May 7–9th)

February 19, 2019 by SharpBrains

_______________

We are proud to announce the first wave of con­firmed Speak­ers to share their inno­v­a­tive work and insights at the 2019 Sharp­Brains Vir­tu­al Sum­mit: The Future of Brain Health, to be held May 7–9th, 2019:

Dr. Tom Insel, Co-founder and Pres­i­dent of Mind­strong Health
Dr. Ainslie Hatch, Direc­tor of Dig­i­tal Ther­a­peu­tics at Otsu­ka Pharmaceutical
David Klein, CEO of Click Ther­a­peu­tics
Char­lie Hartwell, Oper­at­ing Part­ner at The Bridge Builders Collaborative
Louis Gagnon, CEO of Total Brain
Dr. Anna Wexler, sci­ence writer and PI of the Wexler Lab at UPenn
Dr. Eddie Mar­tuc­ci, Founder and CEO of Akili Inter­ac­tive Labs
Ana Maiques, CEO of Neu­ro­electrics
Jan Samzelius, Founder and CEO of Neu­raMetrix
Dr. Peter White­house, Pro­fes­sor of Neu­rol­o­gy at Case West­ern Reserve University
Kito Toset­ti, CEO of CTF MEG International
Ariel Garten, Founder and Chief Evan­ge­lism Offi­cer of Inter­aX­on
Alvaro Fer­nan­dez, CEO and Edi­tor-in-Chief of Sharp­Brains

We can’t wait to discuss and help shape the Future of Brain Health!

_______________

Imag­ine your smart­phone can detect ear­ly signs of anx­i­ety, depres­sion or Parkinson’s Dis­ease — would you like to know? Who else should know … and not know?

Imag­ine a videogame cleared by the FDA to treat ADHD or sub­stance abuse — how will doc­tors pre­scribe it, patients access it, and insur­ers pay for it?

Imag­ine being respon­si­ble for the health & well­ness of your orga­ni­za­tion — how will you nav­i­gate the grow­ing toolk­it of evi­dence-based inter­ven­tions such as exercise/ meditation/ sleep apps/ cog­ni­tive therapies/ biofeedback/ tDCS?

Imag­ine invest­ing $100 mil­lion to help accel­er­ate brain research and appli­ca­tions — how would you ensure that respon­si­ble devel­op­ment meets wise adop­tion?

Imag­ine a free annu­al brain check-up — who should take it, and how could it help prevent/ delay/ treat cog­ni­tive decline and Alzheimer’s Disease?

_______________

LEARN MORE HERE

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: Akili Interactive Labs, Bridge Builders Collaborative, Case-Western-Reserve-University, Click Therapeutics, CTF MEG International, Interaxon, Mindstrong Health, NeuraMetrix, Neuroelectrics, Otsuka Pharmaceutical, sharpbrains, Total Brain, Wexler Lab

Otsuka Pharma and Click Therapeutics enter partnership poised to transform mental healthcare

January 4, 2019 by SharpBrains

Otsu­ka, Click Ther­a­peu­tics part­ner to cre­ate ther­a­py for men­tal ill­ness (Ver­dict Med­ical Devices):

“Otsu­ka Pharmaceutical’s US divi­sion Otsu­ka Amer­i­ca has part­nered with Click Ther­a­peu­tics to devel­op and com­mer­cialise a pre­scrip­tion dig­i­tal ther­a­peu­tic for treat­ing major depres­sive dis­or­der (MDD) [Read more…] about Otsu­ka Phar­ma and Click Ther­a­peu­tics enter part­ner­ship poised to trans­form men­tal healthcare

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: Click Therapeutics, FDA, Major Depressive Disorder, mental healthcare, mental-illness, Otsuka, Otsuka Pharmaceutical

Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest

July 25, 2018 by SharpBrains

Sanofi Backs Click Ther­a­peu­tics as Dig­i­tal Med­i­cines Gain Momen­tum (Xcon­o­my):

“Drug mak­ers are mak­ing more bets on the nascent field of dig­i­tal med­i­cine. The lat­est exam­ple: Click Ther­a­peu­tics announced Mon­day that it grabbed a $17 mil­lion invest­ment led by Sanofi Ven­tures, the Cam­bridge, MA-based ven­ture cap­i­tal arm of the French phar­ma­ceu­ti­cal giant. [Read more…] about Sanofi Ven­tures leads $17M invest­ment in Click Ther­a­peu­tics, final­ist @ 2017 Brain­no­va­tions Pitch Contest

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: Brainnovations, cigarette smoking, Click Therapeutics, Clickotine, digital medicine, digital therapeutics, Pear Therapeutics, Sanofi Ventures, smartphone, smoking cessation, therapeutics, tobacco

« Previous Page
Next Page »

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 35,206 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy